Steve Goldby Partner Office: Palo Alto Email Steve Education A.B., Chemistry, University of North Carolina, Phi Beta Kappa J.D., Georgetown University Law Center

Steve Goldby joined Venrock in 2007 after spending nine years as CEO of Venrock-backed materials science company, Symyx Technologies, where he is currently Executive Chairman.  Steve has served as the CEO of MDL Information Systems, a leading scientific information company, before its sale to Reed Elsevier.  Prior to MDL, he held various management positions at Alza Corporation (acquired by Johnson and Johnson), including President of Alza Pharmaceuticals.  Steve was also President of Dynapol, a specialty chemical company and is a registered patent attorney.

Previously, Steve served on the boards of Vitae Pharmaceuticals (a Venrock-backed company), Ilypsa (acquired by Amgen), Affymax (acquired by GSK), Scios (acquired by Johnson and Johnson), PeopleSoft (acquired by Oracle), Aspect Development (acquired by Itwo), TGV (acquired by Cisco), One Touch Systems (acquired by Apollo Group), Intermolecular, Scientific Software (acquired by Agilent).

"The most successful new enterprises are built when bright, savvy, creative entrepreneurs team with the best venture advisors for their company.  We provide the knowledge and expertise to help entrepreneurs make informed decisions and achieve their goals.  As a former Venrock entrepreneur, I look forward to applying what I've learned to help build the next generation of energy and healthcare companies."